Review Article
Volume 7 Issue 6 - 2020
Incidence of Hypertension with Thyroid Disease
Zia-ul-Sabah*, Shahid Aziz, Adel Masswary and Yakub Sayyad
Department of Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia
*Corresponding Author: Zia-ul-Sabah, Department of Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Received: March 12, 2020; Published: May 29, 2020




Abstract

Thyroid disease increases cardiovascular risk, partly because it can be a secondary cause of hypertension. The pressure changes would be the result of the effects of thyroid hormone levels alterations in the cardiovascular system. In this review, we have described the relationship between thyroid disorders and hypertension and the studies that estimated the prevalence of hypertension related to thyroid disorders. We performed a literature search using PubMed database focusing, but not excluding, on the period 2010-2020. We observed that the prevalence of hypertension in thyroid disease in the reported studies ranged between 9-60%. Literature search indicated that hormonal changes in hypo- and hyperthyroidism can cause many hemodynamic alterations related to hypertension development. Subclinical forms are also causes of negative hemodynamic effects and increase cardiovascular risk. Since hypertension could be one of the first clinical manifestations of thyroid disorders it could be thought that thyroid disorders should be explored as potential cause of underlying secondary hypertension. Cardiovascular risk due to thyroid disorders is an important cause of morbidity and mortality and early diagnosis and treatment could be beneficial. Blood pressure is a non-invasive and economic parameter and it could be considered as an easy detection tool for subclinical forms of thyroid disease.

Keywords: Hypertension; Thyroid Disease; Cardiovascular Risk

References

  1. Charles L., et al. “Secondary Hypertension: Discovering the Underlying Cause” (2017).
  2. Chobanian A V., et al. “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report”. The Journal of the American Medical Association 19 (2003): 2560-2572.
  3. Manolis AA., et al. “Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?” Trends in Cardiovascular Medicine 2 (2020): 57-69.
  4. Taylor PN., et al. “Global epidemiology of hyperthyroidism and hypothyroidism”. Nature Reviews Endocrinology 5 (2018): 301-316.
  5. Berta E., et al. “Hypertension in Thyroid Disorders”. Frontiers in Endocrinology 10 (2019): 482.
  6. Klein I and Ojamaa K. “Thyroid hormone and the cardiovascular system”. The New England Journal of Medicine 7 (2001): 501-509.
  7. Palmieri EA., et al. “Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade”. European Journal of Endocrinology 6 (2004): 757-762.
  8. Stabouli S., et al. “Hypothyroidism and hypertension”. Expert Review of Cardiovascular Therapy11 (2010): 1559-1565.
  9. Danzi S and Klein I. “Thyroid disease and the cardiovascular system”. Endocrinology and Metabolism Clinics of North America 2 (2014): 517-528.
  10. Danzi S., et al. “Effect of triiodothyronine on gene transcription during cardiopulmonary bypass in infants with ventricular septal defect”. The American Journal of Cardiology 6 (2005): 787-789.
  11. Carr AN and Kranias EG. “Thyroid hormone regulation of calcium cycling proteins”. Thyroid6 (2002): 453-457.
  12. Mintz G., et al. “Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment”. The Journal of Clinical Endocrinology and Metabolism 1 (1991): 146-150.
  13. Wieshammer S., et al. “Acute hypothyroidism slows the rate of left ventricular diastolic relaxation”. Canadian Journal of Physiology and Pharmacology 9 (1989): 1007-1010.
  14. Park KW., et al. “The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries”. Anesthesia and Analgesia 4 (1997): 734-738.
  15. Owen PJD., et al. “Thyroid disease and vascular function”. Thyroid6 (2007): 519-524.
  16. Nagasaki T., et al. “Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function”. The Journal of Clinical Endocrinology 5 (2003): 607-612.
  17. Carrillo-Sepulveda MA., et al. “Triiodothyronine Reduces Vascular Dysfunction Associated with Hypertension by Attenuating Protein Kinase G/Vasodilator-Stimulated Phosphoprotein Signaling”. Journal of Pharmacology and Experimental Therapeutics 1 (2019): 88-94.
  18. Neggazi S., et al. “TRα inhibits arterial renin-angiotensin system expression and prevents cholesterol accumulation in vascular smooth muscle cells”. Annales d'Endocrinologie 2 (2019): 89-95.
  19. Ganong WF. “Thyroid hormones and renin secretion”. Life Sciences 7-8 (1982): 561-569.
  20. Skowsky WR and Kikuchi TA. “The role of vasopressin in the impaired water excretion of myxedema”. The American Journal of Medicine 4 (1978): 613-621.
  21. Fommei E and Iervasi G. “The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans”. The Journal of Clinical Endocrinology and Metabolism 5 (2002): 1996-2000.
  22. Van Welsem ME and Lobatto S. “Treatment of severe hypothyroidism in a patient with progressive renal failure leads to significant improvement of renal function”. Clinical Journal of the American Society of Nephrology 6 (2007): 391-393.
  23. Müller B., et al. “Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease”. European Journal of Clinical Investigation 2 (2001): 131-137.
  24. Rizos C V., et al. “Effects of thyroid dysfunction on lipid profile”. The Open Cardiovascular Medicine Journal 5 (2011): 76-84.
  25. Taddei S., et al. “Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy”. The Journal of Clinical Endocrinology and Metabolism 8 (2003): 3731-3737.
  26. De Toledo FG., et al. “Retinoic acid and triiodothyronine stimulate ADP-ribosyl cyclase activity in rat vascular smooth muscle cells”. Biochemical and Biophysical Research Communications 3 (1997): 847-850.
  27. Lu M., et al. “Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review)”. Experimental and Therapeutic Medicine 1 (2015): 3-10.
  28. Ahirwar AK., et al. “Raised TSH is associated with endothelial dysfunction in Metabolic Syndrome: A case control study”. Romanian Journal of Internal Medicine 4 (2017): 212-221.
  29. Balzan S., et al. “Proangiogenic effect of TSH in human microvascular endothelial cells through its membrane receptor”. The Journal of Clinical Endocrinology and Metabolism 5 (2012): 1763-1770.
  30. Huang W., et al. “Functional thyrotropin receptor expression in the ventricle and the effects on ventricular BNP secretion”. Endocrine2 (2014): 328-339.
  31. Masaki M., et al. “Elevated arterial stiffness and diastolic dysfunction in subclinical hypothyroidism”. Circulation Journal 6 (2014): 1494-1500.
  32. Prisant LM., et al. “Hyperthyroidism: a secondary cause of isolated systolic hypertension”. American Journal of Hypertension 8 (2006): 596-599.
  33. Dormandy JA., et al. “Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial”. Lancet 9493 (2005): 1279-1289.
  34. Resnick LM and Laragh JH. “PLasma renin activity in syndromes of thyroid hormone excess and deficiency”. Life Sciences7-8 (1982): 585-586.
  35. Lewicki J and Protter A. “Physiological studies of the natriuretic peptide family”. In: Laragh J, Brenne B, editors. Hypertension: Pathophysiology, Diagnosis and Management”. New York: Raven Press (1995): 1029-1053.
  36. Cesareo R., et al. “Plasmatic endothelin-1 levels in hyperthyroid patients before and after antithyroid therapy”. Minerva Endocrinologica 1 (2000): 1-3.
  37. Taniyama M., et al. “Elevated plasma adrenomedullin level in hyperthyroidism”. European Journal of Clinical Investigation 6 (1996): 454-456.
  38. Garber JR., et al. “Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association”. American Association of Clinical Endocrinologists 6 (2012): 988-1028.
  39. Cappola AR and Ladenson PW. “Hypothyroidism and atherosclerosis”. The Journal of Clinical Endocrinology and Metabolism 6 (2003): 2438-2444.
  40. Dernellis J and Panaretou M. “Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism”. American Heart Journal 4 (2002): 718-724.
  41. Kotsis V., et al. “Hypertension and hypothyroidism: results from an ambulatory blood pressure monitoring study”. Journal of Hypertension 5 (2007): 993-999.
  42. Saito I., et al. “Hypothyroidism as a cause of hypertension”. Hypertension 1 (1983): 112-115.
  43. Gallo EPD., et al. “Masked hypertension in newly diagnosed hypothyroidism: a pilot study”. Journal of Endocrinological Investigation10 (2016): 1131-1138.
  44. Bergus GR., et al. “Lack of association between hypertension and hypothyroidism in postmenopausal women seen in a primary care setting”. Journal of the American Board of Family Medicine 3 (1997): 185-191.
  45. Bergus GR., et al. “The lack of association between hypertension and hypothyroidism in a primary care setting”. Journal of Human Hypertension 4 (1999): 231-235.
  46. Polat Canbolat I., et al. “Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism”. Acta Cardiologica Sinica 5 (2017): 489-494.
  47. Liu D., et al. “A cross-sectional survey of relationship between serum TSH level and blood pressure”. Journal of Human Hypertension 2 (2010): 134-138.
  48. Ittermann T., et al. “Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents”. The Journal of Clinical Endocrinology and Metabolism 3 (2012): 828-834.
  49. He W., et al. “Effect of Levothyroxine on Blood Pressure in Patients with Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis”. Frontiers in Endocrinology 9 (2018): 454.
  50. Ramtahal R and Dhanoo A. “Subclinical hypothyroidism causing hypertension in pregnancy”. Journal of the American Society of Hypertension 9 (2016): 691-693.
  51. Wilson KL., et al. “Subclinical thyroid disease and the incidence of hypertension in pregnancy”. Obstetrics and Gynecology 2-1 (2012): 315-320.
  52. Maraka S., et al. “Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis”. Thyroid4 (2016): 580-590.
  53. Lillevang-Johansen M., et al. “Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk”. Thyroid3 (2019): 332-340.
  54. Muthukumar S., et al. “A Prospective Study on Cardiovascular Dysfunction in Patients with Hyperthyroidism and Its Reversal After Surgical Cure”. World Journal of Surgery 3 (2016): 622-628.
  55. Marvisi M., et al. “Hyperthyroidism and pulmonary hypertension”. Respiratory Medicine 4 (2002): 215-220.
  56. Biondi B., et al. “Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients”. The Journal of Clinical Endocrinology and Metabolism 12 (2000): 4701-4705.
  57. Cai Y., et al. “Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data”. Hypertension Research 10 (2011): 1098-1105.
  58. Endo T., et al. “Re-evaluation of a possible high incidence of hypertension in hypothyroid patients”. American Heart Journal 6 (1979): 684-688.
  59. Streeten DH., et al. “Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension”. Hypertens1 (1988): 78-83.
  60. Luboshitzky R., et al. “Risk factors for cardiovascular disease in women with subclinical hypothyroidism”. Thyroid5 (2002): 421-425.
  61. Denizeria S., et al. “Thyroid disease seen in hypertensive patients”. Atherosclerosis 235 (2014): e192-e301.
  62. Talwalkar P., et al. “Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study”. Diabetes, Metabolic Syndrome and Obesity 12 (2019): 369-376.
  63. Dey A., et al. “A study of the cardiac risk factors emerging out of subclinical hypothyroidism”. Journal of Family Medicine and Primary Care 7 (2019): 2439-2444.
  64. Marcisz C., et al. “Changes of arterial pressure in patients with hyperthyroidism during therapy”. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 7 (2002): CR502-CR507.
  65. Hurxthal LM. “Blood pressure before and after operation in hyperthyroidism”. Archives of Internal Medicine 2 (1931): 167-181.
Citation: Zia-ul-Sabah., et al. “Incidence of Hypertension with Thyroid Disease”. EC Cardiology 7.6 (2020): 72-81.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


June Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the June issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before July 06, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk